The concentrations of cyclic 3', 5'-guanosine monophosphate (cGMP) and cyclic 3', 5'-adenosine monophosphate (cAMP) in the cerebellar and cerebral cortex were measured during lidocaine infusion and during bicuculline-induced seizures in rats. The rats were divided into three groups: control, lidocaine (0.74 mg/min) and bicuculline (1.2 mg/kg). The lidocaine group was divided into four stages according to the EEG pattern; desynchronized, synchronized, seizure and recovery. At the desynchronized and synchronized stages, cGMP and cAMP concentrations in both cerebellar and cerebral cortex remained unchanged except for a modest decrease in cerebral cGMP at the desynchronized stage. At the seizure stage, cerebellar cGMP increased from 5.2 +/- 0.9 to 9.2 +/- 1.4 pmol/mg protein and cerebellar cAMP decreased from 8.9 +/- 0.6 to 6.9 +/- 0.6 pmol/mg protein. These changes in concentrations at the seizure stage returned to the control at the recovery stage. During bicuculline-induced seizures, cGMP and cAMP concentrations increased strikingly in both cerebellar and cerebral cortex. These results indicated that lidocaine-induced seizures were accompanied by significant changes in cerebellar cyclic nucleotide concentrations in rats.
No takes yet. Share an insight, caveat, or question.
Kyoko Yamada (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: